Cargando…
Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
Background: The mortality rate of pancreatic cancer (PC) is equal to its incidence and the majority of PC patients die within a few months of diagnosis. Therefore, a search for new biomarkers useful in the diagnosis and prognosis of PC is ongoing. Objectives: The aim of our study was to compare the...
Autores principales: | Litman-Zawadzka, Ala, Łukaszewicz-Zając, Marta, Gryko, Mariusz, Kulczyńska-Przybik, Agnieszka, Kędra, Bogusław, Mroczko, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504436/ https://www.ncbi.nlm.nih.gov/pubmed/32867211 http://dx.doi.org/10.3390/ijms21176193 |
Ejemplares similares
-
Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer
por: Pawluczuk, Elżbieta, et al.
Publicado: (2021) -
The Significance of CXCL1 and CXCR1 as Potential Biomarkers of Colorectal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2023) -
CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression
por: Pączek, Sara, et al.
Publicado: (2020) -
The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2016) -
The Significance of CXCL1 and CXCL8 as Well as Their Specific Receptors in Colorectal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2020)